Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation

被引:49
作者
Introne, WJ
Phornphutkul, C
Bernardini, I
McLaughlin, K
Fitzpatrick, D
Gahl, WA
机构
[1] NHGRI, MGB, NIH, Bethesda, MD 20892 USA
[2] NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Calgary, Fac Med, Calgary, AB, Canada
关键词
alkaptonuria; homogentisic acid; renal tubular secretion; kidney transplantation; ochronosis;
D O I
10.1016/S1096-7192(02)00121-X
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
In alkaptonuria, homogentisate 1,2-dioxygenase deficiency causes tissue accumulation of homogentisic acid (HGA), followed by signs and symptoms of ochronosis. These include massive urinary excretion of HGA, arthritis and joint destruction, pigmentation of cartilage and connective tissue, and cardiac valve deterioration. We describe a 46-year-old man with alkaptonuria and diabetic renal failure whose plasma HGA concentration was twice that of any other alkaptonuria patient, and whose ochronosis progressed much more rapidly than that of his two alkaptonuric siblings. After renal transplantation, the plasma HGA normalized, and the daily urinary excretion of HGA decreased by 2-3 g. This case illustrates the critical role of renal tubular secretion in eliminating HGA from the body, and suggests that renal transplantation in a uremic patient not only restores HGA excretion, but may also provide homogentisate 1,2-dioxygenase activity for the metabolism of HGA. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 15 条
[1]
NTBC and alkaptonuria [J].
Anikster, Y ;
Nyhan, WL ;
Gahl, WA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :920-921
[2]
COOPER JA, 1957, ARCH PATHOL, V64, P46
[3]
Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2 dioxygenase gene (HGO) [J].
de Bernabé, DBV ;
Jimenez, FJ ;
Aquaron, R ;
de Córdoba, SR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1316-1322
[4]
Mutation and polymorphism analysis of the human homogentisate 1,2-dioxygenase gene in alkaptonuria patients [J].
de Bernabé, DBV ;
Granadino, B ;
Chiarelli, I ;
Porfirio, B ;
Mayatepek, E ;
Aquaron, R ;
Moore, MM ;
Festen, JJM ;
Sanmartí, R ;
Peñalva, MA ;
de Córdoba, SR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (04) :776-784
[5]
The molecular basis of alkaptonuria [J].
FernandezCanon, JM ;
Granadino, B ;
deBernabe, DBV ;
Renedo, M ;
FernandezRuiz, E ;
Penalva, MA ;
deCordoba, SR .
NATURE GENETICS, 1996, 14 (01) :19-24
[6]
The human homogentisate 1,2-dioxygenase (HGO) gene [J].
Granadino, B ;
deBernabe, DBV ;
FernandezCanon, JM ;
Penalva, MA ;
deCordoba, SR .
GENOMICS, 1997, 43 (02) :115-122
[7]
La Du BN, 2001, METABOLIC MOL BASES, V2, P2109
[8]
LADU BN, 1958, J BIOL CHEM, V230, P251
[9]
TREATMENT OF HEREDITARY TYROSINEMIA TYPE-I BY INHIBITION OF 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE [J].
LINDSTEDT, S ;
HOLME, E ;
LOCK, EA ;
HJALMARSON, O ;
STRANDVIK, B .
LANCET, 1992, 340 (8823) :813-817
[10]
LUSTBERG TJ, 1974, CLIN CHIM ACTA, V35, P325